Enlarged Benign-Appearing Cervical Lymph Nodes by Ultrasonography Are Associated with Increased Likelihood of Cancer Somewhere Within the Thyroid in Patients Undergoing Thyroid Nodule Evaluation
- 1 August 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 20 (8), 857-862
- https://doi.org/10.1089/thy.2009.0464
Abstract
Background: Benign-appearing cervical lymph nodes (CLN) are easy to assess during an ultrasonography (US) evaluation for a guided fine-needle aspiration biopsy of a suspicious thyroid nodule, but their clinical significance regarding thyroid cancer risk is not known. Non-malignant-appearing nodes may be an indicator of early malignancy in the thyroid. We hypothesize that there is an increased prediction of thyroid cancer when benign-appearing enlarged CLN (ECLN) > 1 cm in any dimension are present during an US evaluation of thyroid nodules. Method: A review of 269 consecutive patients' charts sent for thyroid nodule assessment that underwent thyroidectomy was conducted to compare ECLN, with the presence of thyroid cancer during an ultrasound-guided fine-needle aspiration biopsy of the thyroid nodule. Surgical excision pathology confirmed all abnormal cytology reports. Results: From the final 265 charts reviewed, 213 had benign thyroid pathology and 52 had thyroid cancer. Sex, number, and size of the biggest thyroid nodule were not different between groups. Patients with cancer were on average 10 years younger and had higher thyroid-stimulating hormone (TSH) values (p < 0.003) as well as a 10-fold increase in enlarged non-malignant-appearing lymph nodes than their peers without cancer. The presence of ECLN had an 82% sensitivity, 90% specificity, and a 68% positive predictive value for thyroid cancer. There was also an 80% negative predictive value when enlarged lymph nodes were not present. In 8 of the 37 (21.6%) patients with malignancy and ECLN, the primary dominant thyroid nodule was negative on cytologic evaluation, but malignancies were confirmed on surgical specimen, in contralateral nodules on the same side as the ECLN. These nodules were mostly subcentimeric, ranging from 0.2 to 1.14 cm and were not biopsied due to their inconspicuous appearance. After multiple logistic regression analysis, enlarged lymph nodes had a 53.8 odds ratio for cancer (20.49–141.33, p < 0.01). Conclusion: Discovering the presence of ECLN in routine assessment of thyroid nodules is an easy and fast surveillance technique that increases the predictive value in diagnosing thyroid cancer, especially when the enlarged lymph nodes are on the same side as the thyroid nodule.Keywords
This publication has 21 references indexed in Scilit:
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinomaSurgery, 2008
- Utilization of ancillary studies in thyroid fine needle aspirates: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science ConferenceDiagnostic Cytopathology, 2008
- Endocrine University: Evolution of a Novel Educational ProgramEndocrine Practice, 2006
- Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinomaSurgery, 2005
- Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference StatementRadiology, 2005
- Thyroid Nodule Shape and Prediction of MalignancyThyroid®, 2004
- Risk for Malignancy of Thyroid Nodules as Assessed by Sonographic CriteriaJournal of Ultrasound in Medicine, 2004
- Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocalityCancer, 2003
- Ultrasound-guided fine-needle aspiration biopsy in the management of thyroid diseaseThe American Journal of Surgery, 1993